Anti-HBS-trough-levels and anti-HBS-half-lives do not differ after intravenous versus intramuscular hepatitis B immunoglobulin administration given for long-term hepatitis B reinfection prophylaxis after liver transplantation

被引：0
|
作者：
Rosenau, Jens
Hooman, Nazanin
Hadem, Johannes
Philipp, Gunnar
Klempnauer, Juergen
Tillmann, Hans L.
Strassburg, Christian P.
Manns, Michael P.
机构：
[1] Medizinische Hochschule Hannover, Hannover, Germany
[2] Medizinische Hochschule Hannover, Visc & Transplant Surg, Hannover, Germany
[3] ZLB Behring, Marburg, Germany
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
779
引用
收藏
页码：479A / 479A
页数：1
相关论文
共 50 条
  • [1] Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
    Burbach, GJ
    Bienzle, U
    Neuhaus, R
    Hopf, U
    Metzger, WG
    Pratschke, J
    Neuhaus, P
    TRANSPLANTATION, 1997, 63 (03) : 478 - 480
  • [2] Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation
    Hooman, Nazanin
    Rifai, Kinan
    Hadem, Johannes
    Vaske, Bernhard
    Philipp, Gunnar
    Priess, Andrea
    Klempnauer, Juergen
    Tillmann, Hans L.
    Manns, Michael P.
    Rosenau, Jens
    LIVER TRANSPLANTATION, 2008, 14 (04) : 435 - 442
  • [3] Ambulatory long-term immunoprophylaxis with intramuscular anti-HBS immunoglobulin to prevent hepatitis B reinfection after orthotopic liver transplantation.
    Faust, D
    Rabenau, H
    Caspary, WF
    Zeuzem, S
    GASTROENTEROLOGY, 2000, 118 (04) : A996 - A996
  • [4] Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
    Mas, A.
    Castells, L.
    Abradelo, M.
    Bernardos, A.
    Paez, A.
    Woodward, M. K.
    Sousa, J. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4253 - 4258
  • [5] Long-Term Results of Hepatitis B Immunoglobulin and Lamuvidine for Hepatitis B Prophylaxis After Liver Transplantation
    Sevmis, S.
    Aktas, S.
    Zia, H. H.
    Atiq, A.
    Akbas, E.
    Selcuk, H.
    Karakayali, H.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 598 - 600
  • [6] Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination
    Marco Fonzo
    Chiara Bertoncello
    Andrea Trevisan
    npj Vaccines, 7
  • [7] Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination
    Fonzo, Marco
    Bertoncello, Chiara
    Trevisan, Andrea
    NPJ VACCINES, 2022, 7 (01)
  • [8] Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
    Naoumov, NV
    Lopes, AR
    Burra, P
    Caccamo, L
    Iemmolo, RM
    de Man, RA
    Bassendine, M
    O'Grady, JG
    Portmann, BC
    Anschuetz, G
    Barrett, CA
    Williams, R
    Atkins, M
    JOURNAL OF HEPATOLOGY, 2001, 34 (06) : 888 - 894
  • [9] INCIDENCE OF HEPATITIS-B INFECTION AFTER ACCIDENTAL EXPOSURE AND ANTI-HBS IMMUNOGLOBULIN PROPHYLAXIS
    POLAKOFF, S
    LANCET, 1980, 1 (8158): : 6 - 8
  • [10] Long-Term Outcomes of Prophylaxis with Entecavir and Hepatitis B Immunoglobulin After Liver Transplantation for Hepatitis B Virus
    Togashi, Junichi
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Arita, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    TRANSPLANTATION, 2016, 100 : S181 - S181
12345